Farallon Capital Management logo

Farallon Capital Management

North America, California, United States, San Francisco

Description

Farallon Capital Management operates as a global institutional asset management firm.

Investor Profile

Farallon Capital Management has made 93 investments, with 11 in the past 12 months and 24% as lead.

Stage Focus

  • Post Ipo Equity (22%)
  • Series B (16%)
  • Series D (16%)
  • Series C (15%)
  • Series A (10%)
  • Series E (5%)
  • Debt Financing (5%)
  • Post Ipo Debt (3%)
  • Series Unknown (3%)
  • Private Equity (2%)

Country Focus

  • United States (61%)
  • China (14%)
  • United Kingdom (3%)
  • France (2%)
  • Israel (2%)
  • India (2%)
  • Germany (2%)
  • Australia (2%)
  • Singapore (2%)
  • Austria (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Health Diagnostics
  • Medical
  • Life Science
  • Biopharma
  • Medical Device
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Farallon Capital Management frequently co-invest with?

Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 14
CA
North America, Massachusetts, United States, Boston
Co-Investments: 14
Casdin Capital
North America, New York, United States, New York
Co-Investments: 15
RTW Investments
North America, New York, United States, New York
Co-Investments: 11
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 14
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 12
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 14
Soleus Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 12
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 11
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 14

Which angels does Farallon Capital Management often collaborate with?

JS
North America, New York, United States, New York
Shared Deals: 1
RG
North America, Texas, United States, Austin
Shared Deals: 1
ER
North America, California, United States, San Francisco
Shared Deals: 1
EL
Europe, England, United Kingdom, London
Shared Deals: 1
OD
Europe, England, United Kingdom, London
Shared Deals: 2
AP
North America, California, United States, San Francisco
Shared Deals: 1
NR
North America, California, United States, San Francisco
Shared Deals: 1
HH
North America, Massachusetts, United States, Boston
Shared Deals: 1
MB
North America, California, United States, San Francisco
Shared Deals: 1
AD
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Farallon Capital Management?

Pentera

Burlington, Massachusetts, United States

Pentera is the market leader in Automated Security Validation

Cloud SecurityCyber SecurityInformation TechnologyNetwork SecurityPenetration TestingSecuritySoftware
Series DMar 12, 2025
Amount Raised: $60,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityFeb 3, 2025
Amount Raised: $185,000,000
Canfor

Vancouver, British Columbia, Canada

Canfor is one of the world’s largest producers of sustainable lumber, pulp and paper.

Green BuildingGreen Consumer GoodsManufacturing
Post Ipo DebtSep 27, 2024
Amount Raised: $315,000,000
Smartsheet

Bellevue, Washington, United States

Smartsheet is a cloud-based work management platform that empowers collaboration, drives better decision-making, and accelerates innovation.

Cloud ManagementEnterpriseSaaSSoftware
Post Ipo DebtSep 24, 2024
Amount Raised: $3,200,000,000
EGenesis

Cambridge, Massachusetts, United States

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

BiopharmaBiotechnologyGeneticsLife ScienceMedical
Series DSep 4, 2024
Amount Raised: $191,000,000
AnaptysBio

San Diego, California, United States

AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 14, 2024
Amount Raised: $100,000,000
Cardurion Pharmaceuticals

Boston, Massachusetts, United States

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series BJul 16, 2024
Amount Raised: $260,000,000
ATLAS CAPITAL GROUP

New York, New York, United States

Atlas Capital Group is a full service real estate investment, development and management firm.

Property ManagementReal Estate Investment
Debt FinancingJul 16, 2024
Amount Raised: $985,000,000
Savara Pharmaceuticals

Austin, Texas, United States

Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection in cystic fibrosis.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityJun 28, 2024
Amount Raised: $100,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityJun 20, 2024
Amount Raised: $130,700,000